FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Waltregny

Research Profile

Disorders

Devices

Suburethral Slings

Procedures

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
David Waltregny
TVT-O: a new gold standard surgical treatment of female stress urinary incontinence?
Julie Leruth; Marc Fillet; David Waltregny
Incidence and risk factors of postoperative stress urinary incontinence following laparoscopic sacrocolpopexy in patients with negative preoperative prolapse reduction stress testing.
Julie Leruth; David Waltregny; Jean de Leval
The inside-out transobturator male sling for the surgical treatment of stress urinary incontinence after radical prostatectomy: midterm results of a single-center prospective study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Waltregny (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David Waltregny
TVT-O: a new gold standard surgical treatment of female stress urinary incontinence?
European urology 2013;63(5):879-80.
2013: Julie Leruth; Marc Fillet; David Waltregny
Incidence and risk factors of postoperative stress urinary incontinence following laparoscopic sacrocolpopexy in patients with negative preoperative prolapse reduction stress testing.
International urogynecology journal 2013;24(3):485-91.
2012: Julie Leruth; David Waltregny; Jean de Leval
The inside-out transobturator male sling for the surgical treatment of stress urinary incontinence after radical prostatectomy: midterm results of a single-center prospective study.
European urology 2012;61(3):608-15.
2011: Jean de Leval; Alexandre Thomas; David Waltregny
The original versus a modified inside-out transobturator procedure: 1-year results of a prospective randomized trial.
International urogynecology journal 2011;22(2):145-56.
2011: David Waltregny
[Surgical treatment of female stress urinary incontinence: where are we in 2011?].
Bulletin et mémoires de l'Académie royale de médecine de Belgique 2011;166(3-4):157-68; discussion 169.
2011: Philippe Kischel; Gabriel Mazzucchelli; David Waltregny; Laurence de Leval; Edwin De Pauw; Yannick Greffe; Vincent Castronovo
Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma.
Proteome science 2011;9(1):63.
2010: M Fleron; Y Greffe; D Musmeci; Anne-Cécile Massart; V Hennequiere; Gabriel Mazzucchelli; David Waltregny; Marie-Claire De Pauw-Gillet; Vincent Castronovo; Edwin De Pauw; Andrei Turtoi
Novel post-digest isotope coded protein labeling method for phospho- and glycoproteome analysis.
Journal of proteomics 2010;73(10):1986-2005.
2010: Philippe Kischel; David Waltregny; Bruno Dumont; Andrei Turtoi; Yannick Greffe; Stephanie Kirsch; Edwin De Pauw; Vincent Castronovo
Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting.
International journal of cancer. Journal international du cancer 2010;126(3):640-50.
2009: Jean-Christophe Pignon; Benjamin Koopmansch; Gregory Nolens; Laurence Delacroix; David Waltregny; Rosita Winkler
Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
Cancer research 2009;69(7):2941-9.
2009: David Waltregny; Jean de Leval
The TVT-obturator surgical procedure for the treatment of female stress urinary incontinence: a clinical update.
International urogynecology journal and pelvic floor dysfunction 2009;20(3):337-48.
2009: Vincent Castronovo; David Waltregny; Olivier Detry; C Coimbra Marques; Arnaud De Roover; Pierre Honoré; Edwin De Pauw; Andrei Turtoi
[Targeted therapy: toward a clean and effective war against cancer].
Revue médicale de Liège 2009;64 Spec No():20-3.
2009: A Thomas; Isabelle Renard; David Waltregny
[Detection of bladder cancer in voided urine samples].
Revue médicale de Liège 2009;64 Spec No():9-14.
2008: Jean de Leval; David Waltregny
The inside-out trans-obturator sling: a novel surgical technique for the treatment of male urinary incontinence.
European urology 2008;54(5):1051-65.
2008: David Waltregny
Editorial comment on: complication rates of tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials comparing tension-free midurethral tapes to other surgical procedures and different devices.
European urology 2008;53(2):308-9.
2008: David Waltregny; Yves Gaspar; Olivier Reul; Wissem Hamida; Pierre Bonnet; Jean de Leval
TVT-O for the treatment of female stress urinary incontinence: results of a prospective study after a 3-year minimum follow-up.
European urology 2008;53(2):401-8.
2007: Denis Mottet; Akeila Bellahcène; Sophie Pirotte; David Waltregny; Christophe Deroanne; Virginie Lamour; Rosette Lidereau; Vincent Castronovo
Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis.
Circulation research 2007;101(12):1237-46.
2007: Philippe Kischel; David Waltregny; Vincent Castronovo
Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
Expert review of proteomics 2007;4(6):727-39.
2007: Nidhi Ahuja; Bjoern Schwer; stefania carobbio; David Waltregny; Brian J North; Vincent Castronovo; Pierre Maechler; Eric Verdin
Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase.
The Journal of biological chemistry 2007;282(46):33583-92.
2007: Wendy Glenisson; Vincent Castronovo; David Waltregny
Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation.
Biochimica et biophysica acta 2007;1773(10):1572-82.
2007: Vincent Castronovo; Philippe Kischel; francois guillonneau; Laurence de Leval; Thierry Deféchereux; Edwin De Pauw; Dario Neri; David Waltregny
Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.
Proteomics 2007;7(8):1188-96.
2007: Helena Stabile; stefania mitola; Emanuela Moroni; Mirella Belleri; Stefania Nicoli; Daniela Coltrini; Francesco Peri; Antonello Pessi; Laura Orsatti; Fabio Talamo; Vincent Castronovo; David Waltregny; Franco Cotelli; Dragana Vukasovic; Marco Presta
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
Blood 2007;109(5):1834-40.
2007: Jean de Leval; Pierre Bonnet; David Waltregny
[TVT-O, a novel minimally invasive technique for the treatment of female stress urinary incontinence from development to clinical experience].
Revue médicale de Liège 2007;62 Spec No():86-94.
2006: Vincent Castronovo; David Waltregny; Philippe Kischel; Christoph Roesli; Giuliano Elia; Rybak Jascha; Dario Neri
A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer.
Molecular & cellular proteomics : MCP 2006;5(11):2083-91.
2006: Thibaut Dassesse; Xavier de Leval; Laurence de Leval; Bernard Pirotte; Vincent Castronovo; David Waltregny
Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage.
European urology 2006;50(5):1021-31; discussion 1031.
2006: Xavier de Leval; Thibaut Dassesse; Jean-Michel Dogné; David Waltregny; Akeila Bellahcène; Valérie Benoit; Bernard Pirotte; Vincent Castronovo
Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents.
The Journal of pharmacology and experimental therapeutics 2006;318(3):1057-67.
2006: Thilo Wedel; Guillaume J J M van Eys; David Waltregny; Wendy Glénisson; V Castronovo; J-M Vanderwinden
Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2006;18(7):526-38.
2006: David Waltregny; Olivier Reul; Balombi Mathantu; Yves Gaspar; Pierre Bonnet; Jean de Leval
Inside out transobturator vaginal tape for the treatment of female stress urinary incontinence: interim results of a prospective study after a 1-year minimum followup.
The Journal of urology 2006;175(6):2191-5.
2006: Philippe Nickers; Adelin Albert; David Waltregny; JEAN-MARIE DENEUFBOURG
Prognostic value of PSA nadir < or =4 ng/mL within 4 months of high-dose radiotherapy for locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 2006;65(1):73-7.
2006: Laurence de Leval; David Waltregny; Jacques Boniver; Robert H Young; Vincent Castronovo; Esther Oliva
Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
The American journal of surgical pathology 2006;30(3):319-27.
2006: Michaël Chaplet; David Waltregny; Cédric Detry; Larry W Fisher; Vincent Castronovo; Akeila Bellahcène
Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness.
International journal of cancer. Journal international du cancer 2006;118(4):850-6.
2005: Jean de Leval; Pierre Bonnet; David Waltregny; Olivier Reul; Yves Gasper; Balombi Mathantu
[Transobturator surgery of female stress urinary incontinence: outside in or inside out? Comparative anatomical study. By Spinosa J.P., Dubuis P.Y., Riedere B. Prog. Urol., 2005, 15 (4):700-706].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2005;15(6):1161-2; author reply 1163-4.
2005: David Waltregny; Wendy Glénisson; Siv Ly Tran; Brian J North; Eric Verdin; Alain Colige; Vincent Castronovo
Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(8):966-8.
2005: Pierre Bonnet; David Waltregny; Olivier Reul; Jean de Leval
Transobturator vaginal tape inside out for the surgical treatment of female stress urinary incontinence: anatomical considerations.
The Journal of urology 2005;173(4):1223-8.
2005: Adelheid Soubry; Jolanda van Hengel; Eef Parthoens; Cecile G Colpaert; Eric Van Marck; David Waltregny; Albert B Reynolds; Frans van Roy
Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment.
Cancer research 2005;65(6):2224-33.
2005: Elisabeth Leruth; Luc Coppens; Robert Andrianne; Pierre Bonnet; David Waltregny; Jean de Leval
[Pelvic lipomatosis associated with glandular cystitis. Report of two cases].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2005;15(1):81-4.
2005: Jean de Leval; David Waltregny
New surgical technique for treatment of stress urinary incontinence TVT-Obturator: new developments and results.
Surgical technology international 2005;14():212-21.
2004: Stéphane Califice; David Waltregny; Vincent Castronovo; Frédéric van den Brûle
[Prostate carcinoma cell lines and apoptosis: a review].
Revue médicale de Liège 2004;59(12):704-10.
2004: David Waltregny; Laurence de Leval; Wendy Glénisson; Siv Ly Tran; Brian J North; Akeila Bellahcène; Ulrich Weidle; Eric Verdin; Vincent Castronovo
Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues.
The American journal of pathology 2004;165(2):553-64.
2004: David Waltregny; Brian J North; F Van Mellaert; Jean de Leval; Eric Verdin; Vincent Castronovo
Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells.
European journal of histochemistry : EJH 2004;48(3):273-90.
2003: Michaël Chaplet; Laurence de Leval; David Waltregny; Cédric Detry; Gino Fornaciari; G Bevilacqua; Larry W Fisher; Vincent Castronovo; Akeila Bellahcène
Dentin matrix protein 1 is expressed in human lung cancer.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(8):1506-12.
2003: Cédric Detry; David Waltregny; P Quatresooz; Michaël Chaplet; Witold Kedzia; Vincent Castronovo; Philippe Delvenne; Akeila Bellahcène
Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix.
Calcified tissue international 2003;73(1):9-14.
2003: Levi A Garraway; Douglas Lin; Sabina Signoretti; David Waltregny; James Dilks; Nandita Bhattacharya; Massimo Loda
Intermediate basal cells of the prostate: in vitro and in vivo characterization.
The Prostate 2003;55(3):206-18.
2002: Robert Andrianne; Raymond Limet; David Waltregny; Jean de Leval
[Hematuria caused by nutcracker syndrome: peroperative confirmation of its presence].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2002;12(6):1323-6.
2002: Neal Lindeman; David Waltregny; Sabina Signoretti; Massimo Loda
Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissection.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2002;11(4):187-92.
2002: David Waltregny; Younes Alami; Nathalie Clausse; Jean de Leval; Vincent Castronovo
Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation.
The Prostate 2002;50(3):162-9.
2001: Olivier Reul; David Waltregny; Jacques Boverie; Jean de Leval; Robert Andrianne
[Pseudotumoral xanthogranulomatous pyelonephritis: diagnosis with percutaneous biopsy and success of conservative treatment].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2001;11(6):1274-6.
2001: David Waltregny; Laurence de Leval; Luc Coppens; E Youssef; Jean de Leval; Vincent Castronovo
Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomy.
European urology 2001;40(5):495-503.
2001: Gonzague De Pinieux; Thierry Flam; Marc Zerbib; P Taupin; Akeila Bellahcène; David Waltregny; Annick Vieillefond; Marie-France Poupon
Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases.
The Journal of urology 2001;166(5):1924-30.
2001: David Waltregny; Irwin Leav; Sabina Signoretti; P Soung; D Lin; FB Merk; Jason Y Adams; N Bhattacharya; N Cirenei; Massimo Loda
Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
Molecular endocrinology (Baltimore, Md.) 2001;15(5):765-82.
2001: Frédéric van den Brûle; David Waltregny; Vincent Castronovo
Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients.
The Journal of pathology 2001;193(1):80-7.
2000: Sabina Signoretti; David Waltregny; J Dilks; B Isaac; D Lin; Levi A Garraway; A Yang; R Montironi; F McKeon; Massimo Loda
p63 is a prostate basal cell marker and is required for prostate development.
The American journal of pathology 2000;157(6):1769-75.
2000: Frédéric van den Brûle; David Waltregny; Fu-Tong Liu; Vincent Castronovo
Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression.
International journal of cancer. Journal international du cancer 2000;89(4):361-7.
2000: David Waltregny; Akeila Bellahcène; Xavier de Leval; B Florkin; U Weidle; Vincent Castronovo
Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(5):834-43.
1999: Pierre Bonnet; Luc Coppens; Robert Andrianne; David Waltregny; V Keppenne; F Leduc; Marianne Fillet; S Ghammad; Jean de Leval
[Surgery, radiotherapy or hormonal therapy in the treatment of prostate cancer].
Revue médicale de Liège 1999;54(11):875-85.
1999: Nathalie Clausse; Frédéric van den Brûle; David Waltregny; F Garnier; Vincent Castronovo
Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion.
Angiogenesis 1999;3(4):317-25.
1998: David Waltregny; Akeila Bellahcène; Ivan Van Riet; Larry W Fisher; M Young; P Fernandez; Walthère Dewé; Jean de Leval; Vincent Castronovo
Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.
Journal of the National Cancer Institute 1998;90(13):1000-8.
1997: Pierre Dehan; David Waltregny; Alain Beschin; Agnès Noel; Vincent Castronovo; Karl Tryggvason; Jean de Leval; Jean-Michel Foidart
Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.
The American journal of pathology 1997;151(4):1097-104.
1997: David Waltregny; Laurence de Leval; S Ménard; Jean de Leval; Vincent Castronovo
Independent prognostic value of the 67-kd laminin receptor in human prostate cancer.
Journal of the National Cancer Institute 1997;89(16):1224-7.
1996: David Waltregny; Vincent Castronovo
Recent advances in prostate cancer metastasis.
Tumori 1996;82(3):193-204.
1995: David Waltregny; Jean de Leval
[Examination of the non-palpable cryptorchid testis].
Acta urologica Belgica 1995;63(2):69-76.
1994: Laurence de Leval; David Waltregny; Roland Greimers; Jacques Boniver
Flow cytometry in prostate cancer: histological and clinical correlation.
Acta urologica Belgica 1994;62(1):37-43.
1993: M A Reginster; V Mazy; David Waltregny; D Lacremans; Christian Focan; C Jardon-Jeghers; Jacques Boniver
[Hepatic angiosarcoma in a patient with autoimmune hepatitis].
Revue médicale de Liège 1993;48(4):220-3.